Finland· FI-REL-REL9647

Omnicef

A cefdinir product containing cefdinir, registered in Finland by Fujisawa GmbH. The same ATC class is registered in 3 of our 19 countries.

ATC J01DD15

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedOmnicefATCJ01DD15REGISTER NO.FI-REL-REL9647PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Cefdinir is registered in 3 of 19 countries.

Countries holding a registration under ATC J01DD15 (cefdinir), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 2 of them publish a price we can compare per daily dose

Cefdinir · ATC J01DD15

3 / 19 countries

  • Finlandprice
  • Japan
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Cefdinir
Manufacturer
Fujisawa GmbH
Country
Finland (FI)
ATC code
J01DD15
ATC class
Cefdinir
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

110 interactions on record for cefdinir.

Graded by severity as the source publishes them — 24 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cefdinir · interactions on record

110 records

  • 24 moderate
  • 86 info

Most severe, free to view

  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefdinir in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefdinir products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c90f8796-1628-4038-96f1-a39ef6b60c39
GET /v1/drugs/c90f8796-1628-4038-96f1-a39ef6b60c39?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.6",
  "form": "jauhe oraalisuspensiota varten",
  "route": null,
  "ddd_unit": "g",
  "strength": "25 mg/ml",
  "atc_label": "kefdiniiri",
  "ma_number": "12998",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL9647",
  "authorised_at": "1997-12-01"
}

See everything about cefdinir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.